Plant Bioscience Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Plant Bioscience Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10925
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Plant Bioscience Ltd (PBL) is a technology management company that offers services in plant, food and microbial science. The company provides intellectual property management, patent advisory, licensing and technology transfer services. It offers patient consultation and management services, which include IP identification and assessment, IP strategy definition and implementation, initial patent application drafting, IP portfolio management, and IP portfolio assessment and due diligence. PBL develops a range of technologies for licensing in plant science, general biotechnology, health and medicine, microbiology, nutritional and food technology industries. It offers assistance and advice related to protecting and commercialising new technology for researcher or research organization. PBL works in partnership with research institutes and universities. PBL is headquartered in Norwich, the UK.

Plant Bioscience Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Plant Bioscience Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deal Details 9
Licensing Agreements 9
Thermo Fisher Scientific Enters into Licensing Agreement with Plant Bioscience 9
Plant Bioscience Enters into Licensing Agreement with Centro Nacional de Biotecnologia 10
Dicerna Pharma Enters Into Licensing Agreement With Plant Bioscience For Baulcombe & Hamilton RNAi Patents 11
Alnylam Pharma Enters Into Licensing Agreement With Plant Bioscience For Baulcombe Patent 12
Plant Bioscience Ltd – Key Competitors 13
Plant Bioscience Ltd – Key Employees 14
Plant Bioscience Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Plant Bioscience Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Thermo Fisher Scientific Enters into Licensing Agreement with Plant Bioscience 9
Plant Bioscience Enters into Licensing Agreement with Centro Nacional de Biotecnologia 10
Dicerna Pharma Enters Into Licensing Agreement With Plant Bioscience For Baulcombe & Hamilton RNAi Patents 11
Alnylam Pharma Enters Into Licensing Agreement With Plant Bioscience For Baulcombe Patent 12
Plant Bioscience Ltd, Key Competitors 13
Plant Bioscience Ltd, Key Employees 14
Plant Bioscience Ltd, Joint Venture 15

List of Figures
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Plant Bioscience Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Plant Bioscience Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NeuroTherm, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary NeuroTherm, Inc. (NeuroTherm) a subsidiary of St. Jude Medical, Inc. is a medical device company that develops, manufactures, and markets product solutions for pain management. The company’s offers products for radiofrequency, vertebral augmentation, and vertebroplasty and intradiscal therap …
  • Salix Pharmaceuticals Ltd:企業のM&A・提携動向(医療分野)
    Summary Salix Pharmaceuticals Ltd (Salix) is a specialty pharmaceutical company. It develops and markets prescription pharmaceutical products for the prevention, treatment and diagnosis of gastrointestinal (GI) diseases. The company also in-licenses and acquires late-stage and marketed proprietary t …
  • Teleca AB:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Teleca AB Mergers and Acquisiti …
  • ASKA Pharmaceutical Co Ltd (4514):製薬・医療:M&Aディール及び事業提携情報
    Summary ASKA Pharmaceutical Co Ltd (ASKA) is a pharmaceutical company that offers quasi-drugs, foods, medical devices and veterinary medicines. The company imports and export pharmaceuticals and medical devices. Its activities comprise production, drug information, and research and development servi …
  • Reservoir Capital Corp.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Reservoir Capital Corp. Mergers …
  • Umicore SA:企業の戦略・SWOT・財務分析
    SummaryUmicore SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - D …
  • Damodar Valley Corporation:企業のM&A・提携動向(発電分野)
    Summary Damodar Valley Corporation (DVC) is an energy utility company. It engages in power generation, transmission, water supply, mining, and rural electrification activities. Major businesses of the company include thermal, and hydroelectric power generation; and water supply for industrial and do …
  • Nippon Paint Holdings Co Ltd (4612):企業の財務・戦略的SWOT分析
    Nippon Paint Holdings Co Ltd (4612) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Shanxi Puda Coal Group Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Shanxi Puda Coal Group Co., Ltd …
  • Activision Blizzard, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Activision Blizzard, Inc. Merge …
  • PFM Packaging Machinery S.p.a.:企業の戦略・SWOT・財務分析
    SummaryPFM Packaging Machinery S.p.a. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compa …
  • Taejoon Pharm Co Ltd:企業のM&A・提携動向(医療分野)
    Summary Taejoon Pharm Co Ltd (Taejoon) is a pharmaceutical company that manufactures and markets ophthalmic agents and other drugs. The company offers powders, spray, eye drops, injections, syrups, liquids for external use, tablets, soft capsules, and hard capsules. Its powder products comprise cool …
  • Perdana Petroleum Bhd (PERDANA):石油・ガス:M&Aディール及び事業提携情報
    Summary Perdana Petroleum Bhd (Perdana Petroleum), a subsidiary of Dayang Enterprise Holdings Bhd, is an offshore marine services provider with focus on the upstream oil and gas industry. The company’s owns and operates a fleet of vessels supporting offshore activities such as exploration, developme …
  • Acosta, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Acosta, Inc. Mergers and Acquis …
  • A2A SpA:企業のM&A・提携・投資分析
    A2A SpA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's A2A SpA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Tele2 AB (TEL2 B):企業の財務・戦略的SWOT分析
    Tele2 AB (TEL2 B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Enerjisa Enerji Uretim AS:企業の発電所・SWOT分析2018
    Enerjisa Enerji Uretim AS - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • A2A SpA (A2A):企業のM&A・提携動向(エネルギー分野)
    Summary A2A SpA (A2A) is a multiutility energy company. The company carries out activities related to generation, trading and distribution of electricity, as well as production and distribution of heat through district heating network. It also conducts activities related to waste management; managem …
  • Rooms To Go.com, Inc.:企業の戦略・SWOT・財務情報
    Rooms To Go.com, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rooms To Go.com, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Mediwatch Plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Mediwatch Plc Mergers and Acqui …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆